Valuation: Quest Diagnostics Incorporated

Market Cap 26.69B 143B 23.94B 22.14B 20.05B 37.45B 2,542B 37.91B 265B 105B 1,330B 100B 98.03B 4,222B P/E 2026 *
23.5x
P/E 2027 * 22.1x
Enterprise Value 31.67B 170B 28.42B 26.27B 23.79B 44.45B 3,017B 44.99B 314B 125B 1,579B 119B 116B 5,011B EV / Sales 2026 *
2.62x
EV / Sales 2027 * 2.46x
Free-Float
67.61%
Yield 2026 *
1.36%
Yield 2027 * 1.36%
1 day-5.57%
3 months+2.86%
6 months+15.33%
Current year+20.45%
Current year 478.31
Extreme 478.31
613.8
1 year 478.31
Extreme 478.31
613.8
3 years 307.83
Extreme 307.83
613.8
5 years 307.83
Extreme 307.83
613.8
10 years 189
Extreme 189
613.8
Manager TitleAgeSince
Chief Executive Officer 63 03/02/2022
Director of Finance/CFO 56 11/07/2022
Chief Tech/Sci/R&D Officer - 06/05/2024
Director TitleAgeSince
Director/Board Member 76 01/12/2004
Director/Board Member 68 07/12/2011
Chairman 63 01/04/2023
Change 5-day change 1-year change 3-year change Capi.($)
-5.57%-.--% - - 26.69B
-1.29%-3.75%+9.43%+32.26% 117B
+2.95%+0.83%-0.69%+107.41% 97.42B
+3.31%+2.67%+123.89%+1,030.28% 59.22B
-0.20%+3.23%-5.94%+90.00% 29.03B
+8.78%+11.27%+38.72%+81.80% 26.86B
+1.26%+2.80%+37.77%+89.80% 26.69B
+2.46%-0.23%+31.22%+404.23% 21.1B
+0.95%+2.20%-16.82%-0.93% 20.61B
-0.13%-1.01%-6.23%+31.16% 16.94B
Average +1.12%-0.16%+23.48%+207.33% 46.05B
Weighted average by Cap. +0.99%-1.33%+25.22%+220.74%

Financials

2026 *2027 *
Net sales 12.08B 64.93B 10.84B 10.02B 9.08B 16.96B 1,151B 17.17B 120B 47.74B 602B 45.35B 44.39B 1,912B 12.62B 67.82B 11.32B 10.47B 9.48B 17.71B 1,202B 17.93B 125B 49.86B 629B 47.36B 46.36B 1,997B
Net income 1.16B 6.25B 1.04B 965M 874M 1.63B 111B 1.65B 11.54B 4.6B 58B 4.37B 4.28B 184B 1.24B 6.65B 1.11B 1.03B 929M 1.74B 118B 1.76B 12.27B 4.89B 61.65B 4.64B 4.54B 196B
Net Debt 4.99B 26.8B 4.47B 4.14B 3.75B 7B 475B 7.08B 49.46B 19.7B 249B 18.72B 18.32B 789B 4.34B 23.3B 3.89B 3.6B 3.26B 6.09B 413B 6.16B 43.01B 17.13B 216B 16.27B 15.93B 686B
Projected Income Statement - Annual - Quest Diagnostics Incorporated
Logo Quest Diagnostics Incorporated
Quest Diagnostics Incorporated is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.7%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica-pathology diagnostic services; - other (2.3%).
Employees
51,500
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Quest Diagnostics Incorporated
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
242.56USD
Average target price
257.27USD
Spread / Average Target
+6.06%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Quest Diagnostics Incorporated